Altasciences is a Canadian company established in 1992, specializing in business services within the research and development sector, particularly in the biotech and pharmaceutical industries. With a workforce ranging from 1,001 to 5,000 employees, the company offers a range of services including clinical trial management, bioanalytical testing, and support for drug development processes. Their expertise encompasses various aspects of clinical research, notably first-in-human trials, where they focus on safety, pharmacokinetics, and participant management. Altasciences also emphasizes the development of antibody-drug conjugates (ADCs), providing advanced bioanalytical services such as ligand binding assays and mass spectrometry to assess pharmacokinetic and pharmacodynamic endpoints. Their published materials reflect a commitment to guiding clients through complex regulatory landscapes and ensuring participant safety during clinical trials. Additionally, case studies highlight their capabilities in preclinical research, particularly in gene therapy and stem cell transplantation. Overall, Altasciences positions itself as a comprehensive partner in the drug development lifecycle, from early research to clinical execution.